Improving Safety in Living Liver Donation: Lessons From Intraoperative Adverse Events in 438 Donors Undergoing a Left Liver Resection.
Journal
Transplantation direct
ISSN: 2373-8731
Titre abrégé: Transplant Direct
Pays: United States
ID NLM: 101651609
Informations de publication
Date de publication:
Sep 2023
Sep 2023
Historique:
received:
02
06
2023
revised:
03
07
2023
accepted:
04
07
2023
medline:
28
8
2023
pubmed:
28
8
2023
entrez:
28
8
2023
Statut:
epublish
Résumé
Donor safety is paramount in living organ donation. Left liver resections are considered safer than right lobe hepatectomies. However, unexpected intraoperative adverse events (iAEs), defined as any deviation from the ideal intraoperative course, can also occur during left liver resections and may be life threatening or lead to postoperative complication or permanent harm to the donor and recipient. Records of 438 liver living donors (LDs) who underwent 393 left lateral sectionectomies (LLSs) and 45 left hepatectomies (LHs) between July 1993 and December 2018 in a pediatric living-donor liver transplantation center were reviewed for the appearance of iAEs that could have influenced the donor morbidity and mortality and that could have contributed to the improvement of the LD surgical protocol. Clinical characteristics of LLS and LH groups were comparable. Nine iAEs were identified, an incidence of 2%, all of them occurring in the LLS group. Seven of them were related to a surgical maneuver (5 associated with vascular management and 2 with the biliary tree approach). One iAE was associated with an incomplete donor workup and the last with drug administration. Each iAE resulted in subsequent changes in the surgical protocol. Donor outcome was at risk by 5 iAEs classed as type a, recipient outcome by 2 iAEs (type b) and both by 2 iAEs (type c). Postoperative complications occurred in 87 LDs (19.9%), with no differences between the LLS and LH groups ( iAEs debriefings induced changes in our LD protocol and may have contributed to reduced morbidity and zero mortality. iAEs analysis can be used as a quality and safety improvement tool in the context of LD procedures, which may include right liver donation, laparoscopic, and robotic living liver graft procurement.
Sections du résumé
Background
UNASSIGNED
Donor safety is paramount in living organ donation. Left liver resections are considered safer than right lobe hepatectomies. However, unexpected intraoperative adverse events (iAEs), defined as any deviation from the ideal intraoperative course, can also occur during left liver resections and may be life threatening or lead to postoperative complication or permanent harm to the donor and recipient.
Methods
UNASSIGNED
Records of 438 liver living donors (LDs) who underwent 393 left lateral sectionectomies (LLSs) and 45 left hepatectomies (LHs) between July 1993 and December 2018 in a pediatric living-donor liver transplantation center were reviewed for the appearance of iAEs that could have influenced the donor morbidity and mortality and that could have contributed to the improvement of the LD surgical protocol.
Results
UNASSIGNED
Clinical characteristics of LLS and LH groups were comparable. Nine iAEs were identified, an incidence of 2%, all of them occurring in the LLS group. Seven of them were related to a surgical maneuver (5 associated with vascular management and 2 with the biliary tree approach). One iAE was associated with an incomplete donor workup and the last with drug administration. Each iAE resulted in subsequent changes in the surgical protocol. Donor outcome was at risk by 5 iAEs classed as type a, recipient outcome by 2 iAEs (type b) and both by 2 iAEs (type c). Postoperative complications occurred in 87 LDs (19.9%), with no differences between the LLS and LH groups (
Conclusions
UNASSIGNED
iAEs debriefings induced changes in our LD protocol and may have contributed to reduced morbidity and zero mortality. iAEs analysis can be used as a quality and safety improvement tool in the context of LD procedures, which may include right liver donation, laparoscopic, and robotic living liver graft procurement.
Identifiants
pubmed: 37636484
doi: 10.1097/TXD.0000000000001531
pmc: PMC10455133
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e1531Informations de copyright
Copyright © 2023 The Author(s). Transplantation Direct. Published by Wolters Kluwer Health, Inc.
Déclaration de conflit d'intérêts
E.B.-R. is funded by the Fonds de la Recherche Scientific (FNRS), Belgium. The remaining authors declare no funding or conflicts of interest.
Références
Transplant Rev (Orlando). 2016 Oct;30(4):247-52
pubmed: 27531698
Transplantation. 2019 Feb;103(2):e39-e47
pubmed: 30308575
Ann Surg. 2013 Jul;258(1):1-7
pubmed: 23728278
Lancet. 1994 May 14;343(8907):1233-4
pubmed: 7909905
Am J Transplant. 2010 Mar;10(3):612-8
pubmed: 20121746
Am J Transplant. 2019 Jul;19(7):2029-2043
pubmed: 30748091
Ann Surg. 2016 Sep;264(3):448-56
pubmed: 27433896
BMJ. 2020 Aug 25;370:m2917
pubmed: 32843333
Mt Sinai J Med. 2012 Mar-Apr;79(2):214-22
pubmed: 22499492
Liver Transpl. 2006 Oct;12(10):1485-8
pubmed: 16952175
Ann Surg. 2015 Dec;262(6):1141-9
pubmed: 25563870
J Surg Res. 2005 Nov;129(1):6-16
pubmed: 16139302
J Am Coll Surg. 2018 Jul;227(1):24-36
pubmed: 29555562
Liver Transpl. 2013 May;19(5):499-506
pubmed: 23172840
Transplantation. 2010 May 27;89(10):1276-82
pubmed: 20216482
Liver Transpl. 2013 May;19(5):472-81
pubmed: 23447523
Am J Transplant. 2010 Feb;10(2):364-71
pubmed: 20415904
Am J Transplant. 2012 May;12(5):1208-17
pubmed: 22335782
Pediatr Transplant. 2006 May;10(3):345-53
pubmed: 16677359
Transplantation. 2016 Jun;100(6):1238-43
pubmed: 27120453
Liver Transpl. 2021 Oct;27(10):1412-1423
pubmed: 34053171
Lancet. 1989 Aug 26;2(8661):497
pubmed: 2570198
Gastroenterology. 2012 Feb;142(2):273-80
pubmed: 22108193
World J Surg. 2019 Oct;43(10):2379-2392
pubmed: 31197439
Ann Surg. 2016 Sep;264(3):492-500
pubmed: 27433909
Transplant Proc. 2018 Nov;50(9):2705-2710
pubmed: 30401381
Pediatr Transplant. 2002 Oct;6(5):378-87
pubmed: 12390423
Ann Surg. 2004 Dec;240(6):1013-24; discussions 1024-6
pubmed: 15570207
Hepatobiliary Surg Nutr. 2019 Oct;8(5):459-469
pubmed: 31673535
J Hepatobiliary Pancreat Surg. 2006;13(2):117-22
pubmed: 16547672
Ann Surg. 2004 Aug;240(2):205-13
pubmed: 15273542
N Engl J Med. 1990 May 24;322(21):1505-7
pubmed: 2336076
Ann Surg. 2013 Mar;257(3):377-82
pubmed: 22895397
Transplant Proc. 2013 Apr;45(3):961-5
pubmed: 23622599
J Am Coll Surg. 2014 Jun;218(6):1120-8
pubmed: 24702887
Transplantation. 2008 Sep 27;86(6):887
pubmed: 18813117
Hepatobiliary Pancreat Dis Int. 2019 Apr;18(2):132-142
pubmed: 30850341
Ann Surg Treat Res. 2018 Oct;95(4):213-221
pubmed: 30310804
Exp Clin Transplant. 2012 Apr;10(2):125-31
pubmed: 22432755
Gastroenterology. 2008 Aug;135(2):468-76
pubmed: 18505689
Lancet. 2003 Aug 30;362(9385):687-90
pubmed: 12957090
Transplantation. 1997 May 27;63(10):1524-8
pubmed: 9175822
Liver Transpl. 2017 Feb;23(2):184-193
pubmed: 27712040
World J Gastroenterol. 2014 Dec 28;20(48):18061-9
pubmed: 25561777
Transplant Proc. 2005 Dec;37(10):4347-9
pubmed: 16387117